Persistent sarcopenia after flare remission in experimental RA responds to dipyridamole and is associated with restoration of adenosine and A2BR signaling.

Journal: Frontiers in pharmacology •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Marco-Bonilla M, Fresnadillo M, Huete-Toral F, et al. (2026). "Persistent sarcopenia after flare remission in experimental RA responds to dipyridamole and is associated with restoration of adenosine and A2BR signaling.". Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1949677